For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

Whether the payer is a for-profit PBM in the U.S. or a single-payer government ... Are there other goods and services, such as medication therapy management, that pharmacies could provide that ...

Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...

Tabula Rasa HealthCare, following its 2023 merger with ExactCare of Cleveland, earlier this month announced it had undertaken ...

He said more rigorous and larger trials are need before PBM therapy should gain wider FDA approval. The FDA’s De Novo approval process is for medical devices that have designs that are unlike ...

In a three-hour committee meeting on Wednesday, senators on the Health and Provider Services Committee revived some ...

By: Whitney Downard Indiana Capital Chronicle For The Republic INDIANAPOLIS — In a three-hour committee meeting on Wednesday, ...

Legislators voted to move five of the six bills forward in the legislative process, including bills banning non-compete ...

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...